Biohit Release: GastroPanel-Screening Results From Kazahkstan 2012-2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In collaboration with the Medical Center of the President’s affairs Administration of the Republic of Kazakhstan and Biohit Oyj, a population-based screening with the GastroPanel test was conducted in Astana (2012-2013), of which the final results are now available. A hospital-derived cohort of over 800 subjects were tested using the GastroPanel assay, which is a simple blood test measuring the serum levels of four stomach-specific biomarkers. This test is designed for two purposes: 1) as the first-line diagnostic tool for all patients complaining dyspeptic symptoms, and 2) for screening of the specific stomach conditions associated with an increased risk for developing gastric cancer. Gastric cancer remains to be among the leading causes of cancer mortality worldwide, and Kazakhstan belongs among the high-incidence countries of gastric cancer.

Help employers find you! Check out all the jobs and post your resume.

Back to news